Dalena DeGrezia is Senior Director, Head of Regulatory Affairs and Compliance for Grünenthal USA. Ms. DeGrezia joined in 2014 and is responsible for developing and implementing regulatory strategies throughout the drug development process. She oversees FDA interactions and coordinates the IND and CTA submissions.
Prior to joining Grünenthal USA, Ms. DeGrezia held a number of positions with increasing responsibility within Regulatory Affairs at pharmaceutical companies in New Jersey, including Novartis, Bayer and Schering Plough. Most recently, Ms. DeGrezia was the Head of US Regulatory Affairs at ProStrakan where her notable achievements include two original NDA approvals for branded pain products and three product launches.
Ms. DeGrezia received her MBA with a Concentration in Marketing from Rutgers University Business School and a Bachelor of Science degree in Chemistry from Montclair State University.